• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在局灶性基底细胞层中断的前列腺结构中染色质粒蛋白 A、miR-146a 和 miR-146b-5p 的异常表达:浸润和激素难治性癌症的早期标志?

Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?

机构信息

Senior Scientist, Diagnostic and Translational Research Center, Henry Jackson Foundation, Gaithersburg, MD 20879, USA.

出版信息

Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44.

PMID:21980038
Abstract

Our recent studies have suggested that prostate tumor invasion is triggered by autoimmunoreactions induced focal basal cell layer disruptions (FBCLD) that selectively favor monoclonal proliferation of the overlying progenitors or of a biologically more aggressive cell clone. As circulating chromogranin-A (CgA) levels are found to correlate with tumor progression and the status of hormone refractoriness, our current study attempted to assess whether CgA-positive cells would be preferentially distributed in epithelial structures with FBCLD. Paraffin-embedded specimens from 50 patients with organ-confined prostate cancer were subjected to double immunohistochemical analysis with monoclonal antibodies to basal cells and CgA. From each case, 3-5 randomly selected fields were digitally photographed and the photos were magnified 400% and the numbers of CgA-positive cells in epithelial structures with non-disrupted, focally disrupted, and lost basal cell layer were separately counted. The averaged number of cell for each category was statistically compared with the Pearson's Chi-square test. In addition, morphologically similar structures with and without CgA-positive cell clusters were microdissected from four selected cases and subjected to a comparison of differential micro-RNA expression levels. Our study revealed that, although isolated CgA-positive cells were seen in both the basal cell layer and the luminal cell population in all cases, only 8 cases (16%) harbored large clusters of CgA-positive cells that were concentrated in a given area, in which all or nearly all cells appeared to share a similar morphological and immunohistochemical profile. Microdissected epithelial structures with CgA-positive cell clusters exhibited a more than 5- and 7-fold lower expression of miR-146a and miR-146b-5p than their CgA-negative counterparts. As focal basal cell layer disruptions and the reduction or loss of miR-146a and miR-146b-5p has been documented to correlate with prostate tumor invasion and hormone refractoriness, our findings suggest that aberrant CgA expression in epithelial structures with FBCLD may represent an early sign of these events.

摘要

我们最近的研究表明,前列腺肿瘤的侵袭是由自身免疫反应引发的,这种反应导致局灶性基底细胞层破坏(FBCLD),从而选择性地促进覆盖的前体细胞或生物学上更具侵袭性的细胞克隆的单克隆增殖。由于循环嗜铬粒蛋白 A(CgA)水平与肿瘤进展和激素抵抗状态相关,我们目前的研究试图评估 CgA 阳性细胞是否会优先分布在具有 FBCLD 的上皮结构中。对 50 例局限性前列腺癌患者的石蜡包埋标本进行了基底细胞和 CgA 的双重免疫组织化学分析。从每个病例中,随机选择 3-5 个视野进行数字摄影,并将照片放大 400%,分别计数上皮结构中无破坏、局灶性破坏和基底细胞层丢失的 CgA 阳性细胞数量。使用 Pearson's Chi-square 检验对每个类别的平均细胞数进行统计学比较。此外,从 4 例选定病例中分离出具有和不具有 CgA 阳性细胞簇的形态相似结构,并进行差异 microRNA 表达水平的比较。我们的研究表明,尽管在所有病例中,CgA 阳性细胞不仅存在于基底细胞层中,也存在于腔细胞群体中,但只有 8 例(16%)存在大量聚集的 CgA 阳性细胞,这些细胞集中在特定区域,其中所有或几乎所有细胞似乎具有相似的形态和免疫组织化学特征。具有 CgA 阳性细胞簇的微分离上皮结构的 miR-146a 和 miR-146b-5p 的表达水平比其 CgA 阴性对应物低 5 倍以上。由于局灶性基底细胞层破坏以及 miR-146a 和 miR-146b-5p 的减少或丢失与前列腺肿瘤侵袭和激素抵抗相关,我们的发现表明,FBCLD 上皮结构中异常的 CgA 表达可能代表这些事件的早期迹象。

相似文献

1
Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?在局灶性基底细胞层中断的前列腺结构中染色质粒蛋白 A、miR-146a 和 miR-146b-5p 的异常表达:浸润和激素难治性癌症的早期标志?
Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44.
2
Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.基底细胞的局灶性变性及由此产生的自身免疫反应:前列腺肿瘤进展和侵袭的新机制。
Med Hypotheses. 2008;70(2):387-408. doi: 10.1016/j.mehy.2007.05.015. Epub 2007 Jul 20.
3
Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.覆盖局灶性破坏的乳腺肌上皮细胞层的细胞簇以及同一导管内的相邻细胞表现出不同的免疫组化和基因特征:对肿瘤进展和侵袭的影响。
Breast Cancer Res. 2003;5(6):R231-41. doi: 10.1186/bcr653. Epub 2003 Oct 3.
4
Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.肿瘤浸润免疫细胞对基底细胞和管腔细胞的不同影响:对肿瘤侵袭和转移的意义
Anticancer Res. 2014 Nov;34(11):6363-80.
5
The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy.免疫组化染色嗜铬粒蛋白 A 在前列腺癌患者中的预后作用受雄激素剥夺治疗的显著影响。
Prostate. 2010 May 15;70(7):718-26. doi: 10.1002/pros.21104.
6
Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion.局灶性前列腺基底细胞层破坏与白细胞浸润相关:基底细胞层破坏和肿瘤侵袭的一种潜在机制。
Cancer Detect Prev. 2005;29(2):161-9. doi: 10.1016/j.cdp.2005.01.004.
7
MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.健康基底和腔上皮乳腺细胞的 microRNA 谱不同,反映在不同的乳腺癌亚型中。
Breast Cancer Res Treat. 2011 Dec;130(3):735-45. doi: 10.1007/s10549-010-1303-3. Epub 2011 Mar 17.
8
Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.嗜铬粒蛋白A在D2期前列腺癌中的免疫组织化学研究
Urology. 2005 Jul;66(1):135-40. doi: 10.1016/j.urology.2005.01.026.
9
[Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].[血浆嗜铬粒蛋白A(CgA)——前列腺癌患者诊断、监测及管理的潜在标志物]
Harefuah. 2006 Jan;145(1):25-9, 78.
10
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.嗜铬粒蛋白A在激素难治性前列腺癌患者中的独立预后作用。
Endocr Relat Cancer. 2005 Mar;12(1):109-17. doi: 10.1677/erc.1.00876.

引用本文的文献

1
The most likely but largely ignored triggering factor for breast (or all) cancer invasion.乳腺癌(或所有癌症)侵袭最可能但很大程度上被忽视的触发因素。
J Cancer. 2023 Feb 27;14(4):573-590. doi: 10.7150/jca.82291. eCollection 2023.
2
The most effective but largely ignored target for prostate cancer early detection and intervention.前列腺癌早期检测和干预最有效但在很大程度上被忽视的靶点。
J Cancer. 2022 Oct 17;13(13):3463-3475. doi: 10.7150/jca.72973. eCollection 2022.
3
Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.局限性前列腺癌患者尿液中的游离微小RNA
Cancers (Basel). 2022 May 12;14(10):2388. doi: 10.3390/cancers14102388.
4
MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5.miR-455-5p 通过靶向 CCR5 抑制前列腺癌的进展。
Biomed Res Int. 2019 Apr 11;2019:6394784. doi: 10.1155/2019/6394784. eCollection 2019.
5
Tumour budding in rectal cancer. A comprehensive review.直肠癌中的肿瘤芽生。全面综述。
Contemp Oncol (Pozn). 2018;22(2):61-74. doi: 10.5114/wo.2018.77043. Epub 2018 Jun 30.
6
EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction.EGBMMDA:用于 miRNA-疾病关联预测的极端梯度提升机。
Cell Death Dis. 2018 Jan 5;9(1):3. doi: 10.1038/s41419-017-0003-x.
7
MiR-146b protects cardiomyocytes injury in myocardial ischemia/reperfusion by targeting Smad4.微小RNA-146b通过靶向Smad4保护心肌缺血/再灌注中的心肌细胞损伤。
Am J Transl Res. 2017 Feb 15;9(2):656-663. eCollection 2017.
8
Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population.miR-499、miR-196a2、miR-146a 和 miR-149 单核苷酸多态性与伊朗人群前列腺癌风险的关联。
J Adv Res. 2016 May;7(3):491-8. doi: 10.1016/j.jare.2016.03.008. Epub 2016 Mar 29.
9
The role of microRNAs in prostate cancer progression.微小RNA在前列腺癌进展中的作用。
Transl Androl Urol. 2013 Sep;2(3):228-41. doi: 10.3978/j.issn.2223-4683.2013.08.01.
10
miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.miR-146b-5p通过靶向TRAF6发挥肿瘤抑制作用,并可预测人类胶质瘤的预后。
Oncotarget. 2015 Oct 6;6(30):29129-42. doi: 10.18632/oncotarget.4895.